Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02535741
Other study ID # K-S-016
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 2006
Est. completion date May 2016

Study information

Verified date February 2024
Source Stryker Orthopaedics
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

An open label, post-market, non-randomised, historical controlled, multi-centre study of the outcomes of the Triathlon Cruciate Retaining (CR) Total Knee System.


Description:

An open label, post-market, non-randomised, historical controlled, multi-centre study of the outcomes of the Triathlon Cruciate Retaining (CR) Total Knee System. The primary objective of this study will be to compare the active range of motion values for the Triathlon CR Total Knee System with those of the Scorpio CR Total Knee System, a historical control group. ROM values will be measured by use of a Goniometer according to the protocol. It is expected that the Triathlon CR Total Knee System group's range of motion is not 5 degrees worse or superior to the control group's range of motion at two-years.


Recruitment information / eligibility

Status Completed
Enrollment 168
Est. completion date May 2016
Est. primary completion date May 2013
Accepts healthy volunteers No
Gender All
Age group 21 Years to 80 Years
Eligibility Inclusion Criteria: 1. Patients willing to sign the Ethic Commission approved, study specific Informed Patient Consent Form. 2. Patients willing and able to comply with scheduled postoperative clinical and radiographic evaluations and rehabilitation. 3. Male or non-pregnant female between the ages of 21-80 years of age at the time of surgery. 4. Patients requiring a primary total knee replacement. 5. Patients with a diagnosis of osteoarthritis (OA), traumatic arthritis (TA), or avascular necrosis (AVN). 6. Patients with intact collateral ligaments. Exclusion Criteria: 1. Patients with inflammatory arthritis. 2. Patients that are morbidly obese, body mass index (BMI) > 40. 3. Patients with a history of total / unicompartmental reconstruction of the affected joint. 4. Patients that have had a high tibial osteotomy or femoral osteotomy. 5. Patients with neuromuscular or neurosensory deficiency, which would limit the ability to assess the performance of the device. 6. Patients with a systemic or metabolic disorder leading to progressive bone deterioration. 7. Patients that are immunologically compromised, or receiving chronic steroids (>30 days duration). 8. Patients bone stock is compromised by disease or infection which cannot provide adequate support and/or fixation to the prosthesis. 9. Patients with a knee fusion to the affected joint. 10. Patients with an active or suspected latent infection in or about the knee joint. 11. Patients with a history of total joint replacement on the opposite knee within less than 1 year. 12. Patients requiring bilateral total knee replacement.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Triathlon CR Total Knee System
Primary total knee replacement

Locations

Country Name City State
Denmark Koge Sygehus Koge Roskilde
Finland Hospital District of South West Finland Turku Westfinland
Germany DRK Klinik Baden-Baden Baden-Baden Baden-Württemberg
Germany Medizinische Universität Hannover Hannover Niedersachsen
Spain Instituto Municipal de Asistencia Sanitaria Barcelona
Spain Hospital Costa del Sol Marbella Andalusia

Sponsors (1)

Lead Sponsor Collaborator
Stryker Orthopaedics

Countries where clinical trial is conducted

Denmark,  Finland,  Germany,  Spain, 

References & Publications (1)

Chaudhary R, Beaupre LA, Johnston DW. Knee range of motion during the first two years after use of posterior cruciate-stabilizing or posterior cruciate-retaining total knee prostheses. A randomized clinical trial. J Bone Joint Surg Am. 2008 Dec;90(12):2579-86. doi: 10.2106/JBJS.G.00995. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Mean Triathlon CR Active Range of Motion (ROM) Comparison of the active ROM values for patients receiving the Triathlon CR Total Knee System with historical active ROM values of the Scorpio CR Total Knee System, a control group by literature review at 2 years post Total Knee Arthroplasty. See Chaudhary R, et al 2008 JBJS included for historical control data. 2 years follow-up
Secondary Investigation of Patient Outcome With Radiographic Analysis Plain radiographs will be obtained for assessment of fixation of the device. Pre-operative, 3 months, 1, 2 and 5 years follow-up
Secondary Investigation of Clinical Performance and Patient Outcome With the Knee Society Score (KSS) The Knee Society Clinical Rating System is comprised of two distinct sub-scores: one for pain, Range of motion (ROM) and joint stability, and one for functional parameters. Sub-scores range from a potential minimum score of 0 to a maximum score of 100 points. Although the specific scores are not distinguished as "excellent," "good," "fair," or "poor," a higher value represents a better outcome. Pre-operative, 3 months, 1, 2, 3, 4 and 5 years follow-up
Secondary Investigation of Clinical Performance and Patient Outcome With the Short Form 12 (SF-12) Patient Questionnaire The SF-12 Health Survey is a 12-item patient completed questionnaire to measure general health and well-being. It includes a physical (PSC) and mental status component (MCS) score; each ranging from 0-100. Low values represent a poor health state and high values represent a good health state. Pre-operative, 3 months, 1, 2, 3, 4 and 5 years follow-up
Secondary Investigation of Clinical Performance and Patient Outcome With the Western Ontario McMaster Osteoarthritis Index (WOMAC) Patient Questionnaire The WOMAC collects information specific to osteoarthritis outcomes. The questionnaire uses a visual analog scale for pain, measuring factors of general pain, stiffness, and physical findings. Pain is scored from 0 to 100 for each set of factors, with 0 indicating no pain and 100 indicating extreme pain. Total WOMAC scores range from 0 to 300. Lower values represent better outcomes. Pre-operative, 3 months, 1, 2, 3, 4 and 5 years follow-up
See also
  Status Clinical Trial Phase
Completed NCT03542981 - Interferential Current Therapy After Total Knee Arthroplasty N/A
Recruiting NCT04458480 - Effect of Fast Inpatient Rehabilitation After TKA
Completed NCT03286543 - Electrical Stimulation for the Treatment of Pain Following Total Knee Arthroplasty Using the SPRINT Beta System N/A
Recruiting NCT06061367 - Muscles Strength and Gait Parameteres After TKA
Recruiting NCT05391828 - Persona MC vs PS RCT With ROSA N/A
Active, not recruiting NCT04850300 - Efficiency Assessment of the Methodology for the Follow-up of Patients With Knee Prostheses Phase 3
Completed NCT05635916 - Trial of Liposomal Bupivacaine for TKA Phase 4
Enrolling by invitation NCT05130216 - Genicular Nerve Radiofrequency Ablation for Chronic Knee Pain After Total Knee Arthroplasty
Completed NCT03206554 - Local Infiltration Analgesia in Total Knee Arthroplasty Phase 2
Withdrawn NCT02495805 - Ultrasound-guided Continuous Proximal Adductor Canal vs Continuous Femoral Nerve Block for Postoperative Pain Control and Rehabilitation Following Total Knee Arthroplasty N/A
Withdrawn NCT01511211 - Duration of Leg Nerve Blocks With Dexamethasone Added to Local Anesthetic Phase 4
Completed NCT01616836 - Optimizing Pain and Rehabilitation After Knee Arthroplasty Phase 3
Not yet recruiting NCT00958945 - Retrospective Chart Analysis in the Effective Use of FloSeal in Post-Operative Joint Replacements N/A
Completed NCT00985920 - Topical Tranexamic Acid for Total Knee Arthroplasty Phase 4
Completed NCT00761956 - A Study to Compare the NexGen CR and CR-Flex Knee Implants N/A
Completed NCT03289247 - Tissue Adhaesive in Wound Closure Following Primary Total Knee Arthroplasty N/A
Terminated NCT03316118 - US Guided GNB vs Saline Injection for TKA Phase 4
Recruiting NCT05962970 - Continuous Adductor Canal Block in Fast Track Total Knee Arthroplasty N/A
Completed NCT03317834 - Navio With Total Knee Arthroplasty
Enrolling by invitation NCT06188091 - Joint Movement to Increase Range of Motion in Knee Joint After Primary Total Knee Arthroplasty N/A